Literature DB >> 17668233

Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells.

Yeon Jeong Kim1, Ji Min Yu, Hye Joon Joo, Hoe Kyu Kim, Hyun Hwa Cho, Yong Chan Bae, Jin Sup Jung.   

Abstract

CD9 belongs to the tetraspanin family and is involved in cell motility, osteoclastogenesis, metastasis, neurite outgrowth, myotube formation, and sperm-egg fusion. CD9 also promotes juxtacrine signaling involved in proliferation and attachment. Varying degrees of CD9 expression have been found in human mesenchymal stem cells. In this study, we determined the functional roles of CD9 in human adipose-derived mesenchymal stem cells (hASCs). The CD9 expression in hASCs was down-regulated during culture expansion. A colony-forming unit assay revealed that the clonal expandability of hASCs was directly correlated with the CD9 expression level of the colony. The CD9(high) cells exhibited an increased ability to proliferate, increased cell adhesiveness, and better in vitro tube formation than the CD9(low) cells. The cellular proliferation and attachment of the CD9(high) cells were inhibited upon treatment with a blocking antibody against CD9 and the transduction of a CD9 miRNA lentivirus. The CD9(high) cells showed higher NF-kappaB promoter activity and higher levels of intercellular adhesion molecule 1 than the CD9(low) cells. Reverse transcription-polymerase chain reaction analysis revealed higher endothelial nitric oxide synthase expression in the CD9(high) cells than in the CD9(low) cells. The engraftment and the proangiogenic action of hASCs in a murine model of hindlimb ischemia were significantly higher in the CD9(high) cells than in the CD9(low) cells. This study indicates that CD9 plays roles in cell proliferation and attachment in vitro as well as in in vivo engraftment and that it can be considered as a useful marker to predict the in vivo efficacy of hASCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668233     DOI: 10.1007/s00424-007-0285-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  69 in total

1.  The major CD9 and CD81 molecular partner. Identification and characterization of the complexes.

Authors:  S Charrin; F Le Naour; M Oualid; M Billard; G Faure; S M Hanash; C Boucheix; E Rubinstein
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 2.  Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells.

Authors:  François Le Naour; Stéphanie Charrin; Valérie Labas; Jean-Pierre Le Caer; Claude Boucheix; Eric Rubinstein
Journal:  Cancer Immunol Immunother       Date:  2004-01-17       Impact factor: 6.968

3.  Severely reduced female fertility in CD9-deficient mice.

Authors:  F Le Naour; E Rubinstein; C Jasmin; M Prenant; C Boucheix
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

4.  Analysis of CD9, CD32 and p67 signalling: use of degranulated platelets indicates direct involvement of CD9 and p67 in integrin activation.

Authors:  J R Slupsky; J C Cawley; C Kaplan; M Zuzel
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

5.  Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.

Authors:  S Inui; S Higashiyama; K Hashimoto; M Higashiyama; K Yoshikawa; N Taniguchi
Journal:  J Cell Physiol       Date:  1997-06       Impact factor: 6.384

6.  Motility related protein 1 (MRP1/CD9) expression in colon cancer.

Authors:  M Mori; K Mimori; T Shiraishi; M Haraguchi; H Ueo; G F Barnard; T Akiyoshi
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

Review 7.  Contributions of the alpha6 integrins to breast carcinoma survival and progression.

Authors:  Jun Chung; Arthur M Mercurio
Journal:  Mol Cells       Date:  2004-04-30       Impact factor: 5.034

8.  Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.

Authors:  M Sho; M Adachi; T Taki; H Hashida; T Konishi; C L Huang; N Ikeda; Y Nakajima; H Kanehiro; M Hisanaga; H Nakano; M Miyake
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

Review 9.  Role of eNOS in neovascularization: NO for endothelial progenitor cells.

Authors:  Dan G Duda; Dai Fukumura; Rakesh K Jain
Journal:  Trends Mol Med       Date:  2004-04       Impact factor: 11.951

10.  Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.

Authors:  M Miyake; M Koyama; M Seno; S Ikeyama
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  11 in total

1.  Characterization of human adipose-derived stem cells and expression of chondrogenic genes during induction of cartilage differentiation.

Authors:  Adila A Hamid; Ruszymah Bt Hj Idrus; Aminuddin Bin Saim; Somasumdaram Sathappan; Kien-Hui Chua
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

2.  Therapeutic doses of multipotent stromal cells from minimal adipose tissue.

Authors:  Nan Zhang; Marilyn A Dietrich; Mandi J Lopez
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

3.  Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?

Authors:  Martin Mueller; Tim G A Wolfs; Andreina Schoeberlein; Antonio W D Gavilanes; Daniel Surbek; Boris W Kramer
Journal:  Mol Cell Pediatr       Date:  2016-02-11

Review 4.  Cancer stem cell surface markers on normal stem cells.

Authors:  Won-Tae Kim; Chun Jeih Ryu
Journal:  BMB Rep       Date:  2017-06       Impact factor: 4.778

5.  Altered properties of feline adipose-derived mesenchymal stem cells during continuous in vitro cultivation.

Authors:  Bo-Yeon Lee; Qiang Li; Woo-Jin Song; Hyung-Kyu Chae; Kyeong Kweon; Jin-Ok Ahn; Hwa-Young Youn
Journal:  J Vet Med Sci       Date:  2018-04-18       Impact factor: 1.267

6.  Alveolar soft-part sarcoma (ASPS) resembles a mesenchymal stromal progenitor: evidence from meta-analysis of transcriptomic data.

Authors:  Luke H Stockwin
Journal:  PeerJ       Date:  2020-06-19       Impact factor: 2.984

7.  Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism.

Authors:  Mujib Ullah; Asma Akbar; Nathan Norton Ng; Waldo Concepcion; Avnesh S Thakor
Journal:  Oncotarget       Date:  2019-05-28

8.  Human Adipose-Derived Stem Cells in Madelung's Disease: Morphological and Functional Characterization.

Authors:  Federica Caponnetto; Ivana Manini; Michela Bulfoni; Nicola Zingaretti; Giovanni Miotti; Carla Di Loreto; Daniela Cesselli; Laura Mariuzzi; Pier Camillo Parodi
Journal:  Cells       Date:  2020-12-30       Impact factor: 6.600

Review 9.  Cellular Heterogeneity in Adipose Tissues.

Authors:  Silvia Corvera
Journal:  Annu Rev Physiol       Date:  2021-02-10       Impact factor: 19.318

10.  Role of motility-related protein-1 in promoting the development of several types of cancer (Review).

Authors:  Han Xuan; Xiaotong Hu; Jinwen Huang
Journal:  Oncol Lett       Date:  2014-01-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.